Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Muath Alobaida, Abdullah Alrumayh, Ayodipupo S Oguntade, Faez Al-Amodi & Mwango Bwalya. (2021) Cardiovascular Safety and Superiority of Anti-Obesity Medications. Diabetes, Metabolic Syndrome and Obesity 14, pages 3199-3208.
Read now
Read now
Articles from other publishers (20)
Cam-Van Thi Vo, Trang Thanh Nguyen, Thien Ngoc Dang, Manh Quoc Dao, Vy Thao Vo, Oanh Thi Tran, Loc Thanh Vu & Thanh-Dao Tran. (2023) Design, synthesis, biological evaluation and molecular docking of alkoxyaurones as potent pancreatic lipase inhibitors. Bioorganic & Medicinal Chemistry Letters, pages 129574.
Crossref
Crossref
Valeria Calcaterra, Virginia Rossi, Alessandra Mari, Francesca Casini, Francesco Bergamaschi, Gian Vincenzo Zuccotti & Valentina Fabiano. (2022) Medical treatment of weight loss in children and adolescents with obesity. Pharmacological Research 185, pages 106471.
Crossref
Crossref
MOHIT KULMI & GAURAV SAXENA. (2022) COMPARISON OF EFFECTS OF SITAGLIPTIN AND A COMBINATION OF NALTREXONE AND BUPROPION IN HIGH FAT DIET-INDUCED OBESITY MODEL IN RATS. Asian Journal of Pharmaceutical and Clinical Research, pages 119-123.
Crossref
Crossref
Mohamed Ismail Nounou, Heba A. Eassa, Nada A. Helal, Khaled AboulFotouh, Ihab Mansoor, Isabel K. Latz, Cindy Zheng, Hadeer A. Eassa, Dina Mohamed, Diana M. Huynh, Abigail R. Wiss, Jessica Sweeney, Monica T. Oakes, Mark M. Mikhail, Nadine Amine, Harshvir Kaur, Natalia Echeverry, Kamila Orzechowski & Doreen Szollosi. (2021) The safety, efficacy and pharmaceutical quality of male enhancement nutraceuticals bought online: Truth versus claim. Journal of Integrative Medicine 19:3, pages 232-242.
Crossref
Crossref
Miradatul Najwa Muhd Rodhi, Fazlena Hamzah & Ku Halim Ku Hamid. (2020) Kinetic Behaviour of Pancreatic Lipase Inhibition by Ultrasonicated A. malaccensis and A. subintegra Leaves of Different Particle Sizes. Bulletin of Chemical Reaction Engineering & Catalysis 15:3, pages 818-828.
Crossref
Crossref
Alan P. Brown, Chandrassegar Saravanan, Patrick Devine, Maria Magnifico, Jiaping Gao, Valerie Beaulieu, Fupeng Ma, Kayo Yasoshima, David Barnes-Seeman & Ken Yamada. (2017) Correlation Between Nasal Epithelial Injury and In Vitro Cytotoxicity Using a Series of Small Molecule Protein Tyrosine Phosphatase 1B Inhibitors Investigated for Reversal of Leptin Resistance in Obesity. International Journal of Toxicology 36:4, pages 303-313.
Crossref
Crossref
Zhengbao Zhu, Qiu Zhang, Hao Peng, Chongke Zhong, Yan Liu, Xinfeng Huangfu, Yunfan Tian, Xiangqin Chao, Aili Wang, Jianhua Jin & Yonghong Zhang. (2017) Plasma proANP 1–98 levels are positively associated with central obesity: A cross-sectional study in a general population of China. Clinica Chimica Acta 469, pages 26-30.
Crossref
Crossref
Palma Lamonaca, Giulia Prinzi, Aliaksei Kisialiou, Vittorio Cardaci, Massimo Fini & Patrizia Russo. (2017) Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives. Marine Drugs 15:3, pages 81.
Crossref
Crossref
Stephanie Jacobs, Cynthia Radnitz & Tom Hildebrandt. (2017) Adherence as a predictor of weight loss in a commonly used smartphone application. Obesity Research & Clinical Practice 11:2, pages 206-214.
Crossref
Crossref
Homayoun L. Daneschvar, Mark D. Aronson & Gerald W. Smetana. (2016) FDA-Approved Anti-Obesity Drugs in the United States. The American Journal of Medicine 129:8, pages 879.e1-879.e6.
Crossref
Crossref
A. J. Krentz, K. Fujioka & M. Hompesch. (2016) Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles. Diabetes, Obesity and Metabolism 18:6, pages 558-570.
Crossref
Crossref
Yu-Chuan Liang, Meng-Ting Yang, Chuan-Ju Lin, Cicero Lee-Tian Chang & Wen-Chin Yang. (2016) Bidens pilosa and its active compound inhibit adipogenesis and lipid accumulation via down-modulation of the C/EBP and PPARγ pathways. Scientific Reports 6:1.
Crossref
Crossref
Dhiren Patel. (2015) Pharmacotherapy for the management of obesity. Metabolism 64:11, pages 1376-1385.
Crossref
Crossref
Debbie L. Hay, Steve Chen, Thomas A. Lutz, David G. Parkes & Jonathan D. Roth. (2015) Amylin: Pharmacology, Physiology, and Clinical Potential. Pharmacological Reviews 67:3, pages 564-600.
Crossref
Crossref
Run-mei Yang, Fang Liu, Zhen-dan He, Min Ji, Xin-xin Chu, Zhuo-ying Kang, Da-yong Cai & Nan-nan Gao. (2015) Anti-obesity effect of total phenylpropanoid glycosides from Ligustrum robustum Blume in fatty diet-fed mice via up-regulating leptin. Journal of Ethnopharmacology 169, pages 459-465.
Crossref
Crossref
Q.-A. Altaf, A. H Barnett & A. A. Tahrani. (2015) Novel therapeutics for type 2 diabetes: insulin resistance. Diabetes, Obesity and Metabolism 17:4, pages 319-334.
Crossref
Crossref
Michael Karbiener & Marcel Scheideler. (2014) MicroRNA Functions in Brite/Brown Fat — Novel Perspectives towards Anti-Obesity Strategies. Computational and Structural Biotechnology Journal 11:19, pages 101-105.
Crossref
Crossref
Yasuhiro Sawai, Masahiro Mizuno, Tatsuya Ito & Mitsuhisa Yamano. (2014) Synthesis of a stable triformylmethane synthon and its scalable application to 7-acylamino-3-formylquinoline syntheses. Tetrahedron 70:14, pages 2370-2377.
Crossref
Crossref
Deepak K. Rajpal, Xiaoyan A. Qu, Johannes M. Freudenberg & Vinod D. Kumar. 2014. Biomedical Literature Mining. Biomedical Literature Mining
171
206
.
G W Kim, J E Lin, E S Blomain & S A Waldman. (2013) Antiobesity Pharmacotherapy: New Drugs and Emerging Targets. Clinical Pharmacology & Therapeutics 95:1, pages 53-66.
Crossref
Crossref